Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study.
Publication
, Journal Article
Hunter, DJ; Collins, JE; Deveza, L; Hoffmann, SC; Kraus, VB
Published in: Skeletal Radiol
November 2023
Currently, no disease-modifying therapies are approved for osteoarthritis (OA) use. One obstacle to trial success in this field has been our existing endpoints' limited validity and responsiveness. To overcome this impasse, the Foundation for the NIH OA Biomarkers Consortium is focused on investigating biomarkers for a prognostic context of use for subsequent qualification through regulatory agencies. This narrative review describes this activity and the work underway, focusing on the PROGRESS OA study.
Duke Scholars
Published In
Skeletal Radiol
DOI
EISSN
1432-2161
Publication Date
November 2023
Volume
52
Issue
11
Start / End Page
2323 / 2339
Location
Germany
Related Subject Headings
- Prognosis
- Osteoarthritis
- Nuclear Medicine & Medical Imaging
- Humans
- Biomarkers
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hunter, D. J., Collins, J. E., Deveza, L., Hoffmann, S. C., & Kraus, V. B. (2023). Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiol, 52(11), 2323–2339. https://doi.org/10.1007/s00256-023-04284-w
Hunter, David J., Jamie E. Collins, Leticia Deveza, Steven C. Hoffmann, and Virginia B. Kraus. “Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study.” Skeletal Radiol 52, no. 11 (November 2023): 2323–39. https://doi.org/10.1007/s00256-023-04284-w.
Hunter DJ, Collins JE, Deveza L, Hoffmann SC, Kraus VB. Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiol. 2023 Nov;52(11):2323–39.
Hunter, David J., et al. “Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study.” Skeletal Radiol, vol. 52, no. 11, Nov. 2023, pp. 2323–39. Pubmed, doi:10.1007/s00256-023-04284-w.
Hunter DJ, Collins JE, Deveza L, Hoffmann SC, Kraus VB. Biomarkers in osteoarthritis: current status and outlook - the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiol. 2023 Nov;52(11):2323–2339.
Published In
Skeletal Radiol
DOI
EISSN
1432-2161
Publication Date
November 2023
Volume
52
Issue
11
Start / End Page
2323 / 2339
Location
Germany
Related Subject Headings
- Prognosis
- Osteoarthritis
- Nuclear Medicine & Medical Imaging
- Humans
- Biomarkers
- 3202 Clinical sciences
- 1103 Clinical Sciences